CD4 and myeloid sarcoma: Overall, the identified functions of CD4+Notch2+Foxp3lo cells are consistent with previously reported results, including the failure of TNF antagonists to successfully treat MS and increased numbers of CNS−infiltrated Treg cells during the remission phase of EAE.